REG - Reckitt Benckiser Gp - Statement re NEC Litigation

Reckitt BenckiserAnnouncement

15/03/2024 15:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240315:nRSO1116Ha&default-theme=true

RNS Number : 1116H  Reckitt Benckiser Group PLC  15 March 2024

RECKITT STANDS BY THE SAFETY OF ITS INFANT FORMULA PRODUCTS
Statement is in response to a verdict received in Illinois state court on 13 March in one case concerning Necrotising enterocolotis (NEC)

Reckitt/Mead Johnson stands by the safety of our products.  We strongly
reject any assertion that any of our products cause NEC, a serious
gastrointestinal problem that mostly affects premature infants.

While we continue to offer our deepest condolences to Ms. Watson, we strongly
disagree with the jury's decision to fault Mead Johnson and award damages. We
continue to believe that the allegations from the plaintiff's lawyers in this
case were not supported by the science or experts in the medical community.
This was underscored during the trial by a dozen neonatologists.

It is important to note that this is a single verdict in a single case and
should not be extrapolated.

This case, and others like it, exclusively involve products used under the
strict supervision of neonatologists in neonatal intensive care units and
provide lifesaving nutrition options for vulnerable premature infants.

We are of course, surprised and deeply disappointed with the verdict and will
pursue all options to have it overturned.

http://www.reckitt.com/thisisreckitt

-ENDS-

CONTACT DETAILS:

Richard Joyce, Investor Relations, Reckitt: Richard.Joyce@reckitt.com

Patty O'Hayer, External Affairs, Reckitt: Patty.OHayer@reckitt.com

About Reckitt:

Reckitt* exists to protect, heal and nurture in the pursuit of a cleaner,
healthier world. We believe that access to the highest-quality hygiene,
wellness and nourishment is a right, not a privilege.

Reckitt is the company behind some of the world's most recognisable and
trusted consumer brands in hygiene, health and nutrition, including Air Wick,
Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon,
Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet,
Woolite and more.

Every day, around 30 million Reckitt products are bought globally. We always
put consumers and people first, seek out new opportunities, strive for
excellence in all that we do and build shared success with all our partners.
We aim to do the right thing, always.

We are a diverse global team of c. 40,000 colleagues. We draw on our
collective energy to meet our ambitions of purpose-led brands, a healthier
planet and a fairer society.  Find out more, or get in touch with us at
www.reckitt.com

* Reckitt is the trading name of the Reckitt Benckiser group of companies

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  STRDZGMFKKMGDZM